A kinase-independent role for CDK8 in BCR-ABL1+ leukemia

A kinase-independent role for CDK8 in BCR-ABL1+ leukemia

Cyclin-dependent kinases are deregulated in blood cancers. Here, the authors show that CDK8, independent of its kinase activity, regulates mTOR signalling for the maintenance of BCR-ABL1+ leukemia, and that the dual inhibition of CDK8 and mTOR signalling induces apoptosis in these cells.

Bibliographic Details
Main Authors:	Ingeborg Menzl, Tinghu Zhang, Angelika Berger-Becvar, Reinhard Grausenburger, Gerwin Heller, Michaela Prchal-Murphy, Leo Edlinger, Vanessa M. Knab, Iris Z. Uras, Eva Grundschober, Karin Bauer, Mareike Roth, Anna Skucha, Yao Liu, John M. Hatcher, Yanke Liang, Nicholas P. Kwiatkowski, Daniela Fux, Andrea Hoelbl-Kovacic, Stefan Kubicek, Junia V. Melo, Peter Valent, Thomas Weichhart, Florian Grebien, Johannes Zuber, Nathanael S. Gray, Veronika Sexl
Format:	Article
Language:	English
Published:	Nature Portfolio 2019-10-01
Series:	Nature Communications
Online Access:	https://doi.org/10.1038/s41467-019-12656-x

Similar Items

P1310: A ROBUST APPROACH FOR THE GENERATION OF FUNCTIONAL HEMATOPOIETIC PROGENITOR CELL LINES TO MODEL LEUKEMIC TRANSFORMATION
by: E. Doma, et al.
Published: (2022-06-01)

P1412: UNCOUPLING INK4 PROTEINS FROM CDK4/CDK6 IN HEMATOPOIETIC STEM CELLS
by: A. Schirripa, et al.
Published: (2022-06-01)

Isolation, Maintenance and Expansion of Adult Hematopoietic Stem/Progenitor Cells and Leukemic Stem Cells
by: Isabella Maria Mayer, et al.
Published: (2022-03-01)

STAT5A and STAT5B—Twins with Different Personalities in Hematopoiesis and Leukemia
by: Barbara Maurer, et al.
Published: (2019-11-01)

CDK8-Novel Therapeutic Opportunities
by: Ingeborg Menzl, et al.
Published: (2019-06-01)

SETD2 in MLL-rearranged leukemia – a complex case
by: Anna Skucha, et al.
Published: (2018-07-01)

Roles of SETD2 in Leukemia—Transcription, DNA-Damage, and Beyond
by: Anna Skucha, et al.
Published: (2019-02-01)

S227: SBNO2 IS A SPECIFIC DEPENDENCY OF STAT3-DRIVEN T-CELL MALIGNANCIES
by: T. Brandstoetter, et al.
Published: (2022-06-01)

T Cell-Intrinsic CDK6 Is Dispensable for Anti-Viral and Anti-Tumor Responses In Vivo
by: Klara Klein, et al.
Published: (2021-06-01)

A target-disease network model of second-generation BCR-ABL inhibitor action in Ph+ ALL.
by: Uwe Rix, et al.
Published: (2013-01-01)

Core Fucosylation Regulates the Function of Pre-BCR, BCR and IgG in Humoral Immunity
by: Yuhan Sun, et al.
Published: (2022-03-01)

CDK6 Inhibition: A Novel Approach in AML Management
by: Iris Z. Uras, et al.
Published: (2020-04-01)

Loss of STAT3 in Lymphoma Relaxes NK Cell-Mediated Tumor Surveillance
by: Eva Maria Putz, et al.
Published: (2014-01-01)

P444: IDENTIFICATION OF FUNCTIONAL GENETIC DEPENDENCIES IN CEBPA-MUTATED ACUTE MYELOID LEUKEMIA
by: L. Proietti, et al.
Published: (2022-06-01)

Pterostilbene downregulates BCR/ABL and induces apoptosis of T315I-mutated BCR/ABL-positive leukemic cells
by: Shohei Kawakami, et al.
Published: (2022-01-01)

Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I
by: Mian Afsar, et al.
Published: (2012-09-01)

P1407: CDK6 IN HEMATOPOIETIC STEM CELLS: MORE THAN A CELL CYCLE KINASE
by: I. Mayer, et al.
Published: (2022-06-01)

An In-house Method for Molecular Monitoring of BCR-ABL
by: Hakkı Ogun Sercan, et al.
Published: (2012-12-01)

Swiprosin 1 – regulator of proximal BCR signaling
by: Mielenz D, et al.
Published: (2009-02-01)

Editorial: BCR Signaling and B Cell Activation
by: Wanli Liu, et al.
Published: (2020-01-01)

No Benefit of BCR-ABL1 Screening in Polycythemia
by: STEPHEN E. LANGABEER
Published: (2016-07-01)

V Brazilian Conference on Rheology (BCR 2010)
by: Naccache Monica F., et al.
Published: (2010-07-01)

The molecular signature of BCR::ABLP210 and BCR::ABLT315I in a Drosophila melanogaster chronic myeloid leukemia model
by: Amro Baassiri, et al.
Published: (2024-04-01)

The HSP90 inhibitor KW-2478 depletes the malignancy of BCR/ABL and overcomes the imatinib-resistance caused by BCR/ABL amplification
by: Dachuan Zeng, et al.
Published: (2022-05-01)

BCR and its mutants, the reciprocal t(9;22)-associated ABL/BCR fusion proteins, differentially regulate the cytoskeleton and cell motility
by: Puccetti Elena, et al.
Published: (2006-11-01)

Phospho-Profiling Linking Biology and Clinics in Pediatric Acute Myeloid Leukemia
by: Angela Schumich, et al.
Published: (2020-02-01)

Complement Receptor Type 1 (CR1, CD35), the Inhibitor of BCR-Mediated Human B Cell Activation, Differentially Regulates TLR7, and TLR9 Induced Responses
by: Bernadett Mácsik-Valent, et al.
Published: (2019-07-01)

Peptides spanning the junctional region of both the abl/bcr and the bcr/abl fusion proteins bind common HLA class I molecules.
by: Berke, Z, et al.
Published: (2000)

Combined inhibition of BCR-ABL1 and the proteasome as a potential novel therapeutic approach in BCR-ABL positive acute lymphoblastic leukemia
by: Saskia Maletzke, et al.
Published: (2022-01-01)

Arp2/3 complex-driven spatial patterning of the BCR enhances immune synapse formation, BCR signaling and B cell activation
by: Madison Bolger-Munro, et al.
Published: (2019-06-01)

Combined inhibition of BCR-ABL1 and the proteasome as a potential novel therapeutic approach in BCR-ABL positive acute lymphoblastic leukemia.
by: Saskia Maletzke, et al.
Published: (2022-01-01)

Transforming and tumorigenic activity of JAK2 by fusion to BCR: molecular mechanisms of action of a novel BCR-JAK2 tyrosine-kinase.
by: Álvaro Cuesta-Domínguez, et al.
Published: (2012-01-01)

Alternative end-joining in BCR gene rearrangements and translocations
by: Bai Wanyu, et al.
Published: (2022-05-01)

Effect of Ras Inhibition in Hematopoiesis and BCR/ABL Leukemogenesis
by: Baum Karina J, et al.
Published: (2008-06-01)

AKT2 deficiency impairs formation of the BCR signalosome
by: Zuochen Du, et al.
Published: (2020-04-01)

Advances in antibody discovery from human BCR repertoires
by: Zichang Xu, et al.
Published: (2022-10-01)

BCR/ABL positive thrombocythemia: a diagnostic dilemma
by: Lubna Zafar, et al.
Published: (2017-01-01)

The regulators of BCR signaling during B cell activation
by: Yue Wen, et al.
Published: (2019-10-01)

The functional interplay between the t(9;22)-associated fusion proteins BCR/ABL and ABL/BCR in Philadelphia chromosome-positive acute lymphatic leukemia.
by: Anahita Rafiei, et al.
Published: (2015-04-01)

A Small Molecule Inhibitor, OGP46, Is Effective against Imatinib-Resistant BCR-ABL Mutations via the BCR-ABL/JAK-STAT Pathway
by: Liuya Wei, et al.
Published: (2020-09-01)